A new 5% passive stake by an individual investor is routine and carries no activist intent. Monitor for any subsequent conversion to a 13D or additional share accumulation, which would signal a change in strategy. The prior Baker Bros. 13G/A (filed May 2026) remains the larger institutional holder to watch.
Price Chart
Executive Summary
Nachum Labkowski filed a Schedule 13G disclosing a 5.0% passive stake in KALA BIO, Inc., representing 966,991 common shares as of October 14, 2026. This is a new filing (not an amendment) by an individual investor, with no prior 13G or 13D on file from this filer. The stake is held directly (57,211 shares) and through Halevi Enterprises LLC (909,720 shares), with sole voting and dispositive power.
Key Financial Metrics
Key Facts
- Nachum Labkowski disclosed a 5.0% passive stake in KALA BIO, Inc. via Schedule 13G
- Total beneficial ownership: 966,991 common shares as of October 14, 2026
- Stake includes 57,211 shares held directly and 909,720 shares held through Halevi Enterprises LLC
- Percentage calculated based on 19,339,786 shares outstanding as of August 14, 2026 (per Form 10-Q)
- Filer certifies passive intent under Rule 13d-1(c) — no intent to influence or change control
- This is a new filing, not an amendment; no prior 13G or 13D from this filer on record
Financial Impact
5.0% passive stake valued at approximately $X (no market price provided in filing)
Risk Factors
- No indication of activist intent — passive filing limits near-term catalyst potential
- Individual investor with no public track record; conviction level unclear
- Stake is at the 5% threshold — minimal premium over disclosure requirement
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0002123249-26-000002 |
| Document: 0002123249-26-000002-index.html | 0002123249-26-000002 |
| Document: 0002123249-26-000002.txt | 0002123249-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | SC 13G | $0.1926 | awaiting T+20 | awaiting T+20 | $0.1760 (−8.62%) |
Sep 24, 2026 4w ago | Press Release | $0.5600 $0.1860 | ▼ −66.79% | ▼ −66.37% | $0.1760 (−68.57%) |
Aug 28, 2026 8w ago | 8-K | $0.6901 $0.4502 | ▲ +34.76% | ▲ +35.02% | $0.1760 (+74.50%) |
Jul 22, 2026 13w ago | 424B5 | $0.6103 $0.8401 | ▼ −37.65% | ▼ −34.35% | $0.1760 (+71.16%) |
Jun 26, 2026 17w ago | EFFECT | $2.52 $0.6103 | ▲ +75.78% | ▲ +77.04% | $0.1760 (+93.02%) |
May 7, 2026 24w ago | S-3 | $3.95 $2.06 | ▼ −47.85% | ▼ −47.87% | $0.1760 (−95.54%) |
Mar 4, 2026 33w ago | Press Release | $17.25 $0.1630 | ▼ −99.06% | ▼ −94.64% | $0.1760 (−98.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers